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ABSTRACT 
This dissertation includes two projects and an R package for the 1st project, focusing 
on choosing cutoff values to estimate the sensitivity and specificity for continuous 
diagnostic tests. A continuous diagnostic test needs to be dichotomized to generate positive 
and negative test outcomes by choosing a cutoff value. The choice of the cutoff value 
depends on the estimates of the sensitivity and specificity of the dichotomized test with 
this cutoff. There are two challenges during this process: 1) a typical experiment to validate 
a new diagnostic test usually involves multiple observations from the same subjects, 
resulting in correlated data values. This correlation increases the complexity of calculating 
the confidence intervals of the sensitivity and specificity given the true statuses. 2) In many 
diagnostic trials, the true statuses are unknown, which make it difficult even to calculate 
the point estimates of the sensitivity and specificity. In the 1st project (Chapter 2), we 
propose a method to calculate the confidence intervals of sensitivity and specificity with 
the true statuses of subjects given based on a parametric model for the correlated 
continuous diagnostic test data. In the second project (Chapter 3), we focus on the 
challenge of unknown statuses. Due to the lack of the statuses, only the model-based 
method can be used to estimate the sensitivity and specificity. However, the estimations of 
model parameters are difficult because of the unknown statuses.  We propose a Bayesian 
model with latent variables to model the unknown statuses. In Chapter 4, I create an R 
package for the 1st project for future uses.  
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CHAPTER 1.    GENERAL INTRODUCTION 
1.1 Background 
A receiver operating characteristic (ROC) curve is a useful tool to assess and compare 
binary classification tests [Delong 1988, Hanley 1982, and Metz 1978]. Sensitivity and 
specificity are building bricks of ROC curves. Sensitivity, also known as the true positive rate, 
is defined as the proportion of positive tests for the diseased group, which is written as Pr⁡(𝑇 +
|𝐷) , where 𝐷  denotes the diseased group and 𝑇 +  denotes the positive tests. Similarly, 
specificity, also known as the true negative rate, is defined as Pr⁡(𝑇 − |𝐷𝑐), where 𝐷𝑐 denotes 
the non-diseased group and  𝑇 − denotes the negative tests. Nowadays, the ROC curve is 
widely used in continuous diagnostic tests. For continuous data, positive and negative test 
results are separated by the select cutoff value. However, there are two challenges during the 
process of estimating the sensitivity and specificity: 1) A typical experiment to validate a new 
diagnostic test usually involves multiple observations from the same subjects, resulting in 
correlated data values. The correlation influences the variances of the estimated sensitivity and 
specificity and thus the confidence intervals (CIs). 2) In many clinical diagnostic trials, the true 
statuses of patients are unknown. The unknown statuses will i) make the model-based method 
to be the only choice to estimate the sensitivity and specificity ii) increase the complexity to 
analyze the data. The construction of proper statistical methods for either of these two 
challenges is crucial for estimating the sensitivity and specificity and choosing the cutoffs. 
In this dissertation, we propose a model based on the normal distribution to analyze the 
correlated data and then calculate the CIs of sensitivity and specificity based on the model 
parameters for the 1st challenge; we also propose a model with a latent variable to model the 
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data with unknown statuses for the 2nd challenge. Due to the complexity of the model, we use 
the Bayesian method together with the Markov chain Monte Carlo (MCMC) to make inference 
for the model parameters. 
 
1.2 Dissertation Organization 
This dissertation consists of three main chapters (Chapters 2, 3, and 4). In the 1st project 
(Chapter 2), we propose a model based on the normal distribution for the correlated and 
continuous data. The variances of the estimated sensitivity and specificity are derived as 
functions of model parameters. The logit transformation and the corresponding back 
transformation are applied to avoid the case that the CIs exceed the range of [0, 1]. We apply 
both the newly-proposed method and the existing methods to simulated data sets to compare 
the performances of different methods. In the 2nd project (Chapter 3), we model the unknown 
statuses as a latent variable in the proposed normal-distribution based model. The Bayesian 
method combined with MCMC is used to get the samplings of the posterior distribution of 
each model parameter. The model parameters are estimated from the samplings of the 
corresponding posterior distributions. Given a desired value of sensitivity or specificity, the 
cutoff is estimated by inversing the model-based estimate of sensitivity or specificity. We 
perform the simulation studies to see if our method can recover the true model parameters and 
the theoretical value of the cutoff for the desired sensitivity or specificity. In Chapter 4, I build 
an R package for the 1st project for future use. The manual of the R project is the main 
component of Chapter 4. Finally, I make a general discussion and conclusion in Chapter 5.  
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CHAPTER 2.    CHOOSING CUTOFF VALUES FOR 
CORRELATED CONTINUOUS DIAGNOSTIC DATA: 
ADJUSTMENT FOR CONFIDENCE INTERVAL 
ESTIMATIONS OF SENSITIVITY AND SPECIFICITY 
Abstract: A continuous diagnostic test needs to be dichotomized to generate positive 
and negative test outcomes by choosing a cutoff value. The choice of the cutoff value depends 
on the estimates of the sensitivity and specificity of the dichotomized test with this cutoff. A 
typical experiment to validate a new diagnostic test usually involves multiple observations 
from the same subjects, resulting in correlated data values. Currently, methods to calculate 
interval estimates of sensitivity and specificity are available for binary data. In this paper, we 
propose a method to calculate the confidence intervals of sensitivity and specificity based on 
a parametric model for the correlated continuous diagnostic test data. Simulation studies show 
that our proposed method outperforms the current methods for binary correlated data in terms 
of the coverage probability and calculating efficiency.  In addition, we provide an application 
to choosing cutoff values for the influenza A virus test in swine. 
2.1 Introduction 
As discussed in section 1.1, sensitivity and specificity are important statistical measures 
for binary tests. In many biological clinical tests, the enzyme-linked immunosorbent assay 
(ELISA) or the polymerase chain reaction (PCR) is used to collect data from multiple subjects. 
The raw data for these tests are usually continuous and correlated. For example, a typical 
veterinary test often collects data at different times for each of a group of subjects (usually 
swine or rats). Data collected from the same subjects are correlated while data from different 
subjects tend to be uncorrelated. For such data, a cutoff point is selected to separate positive 
and negative test results and further to evaluate sensitivity and specificity. Large values of 
4 
sensitivity and specificity are favorable. However, the magnitudes of sensitivity and specificity 
change along opposite directions as the cutoff changes. Therefore, a trade-off between 
sensitivity and specificity needs to be made by selecting a proper cutoff. The intra-subject 
correlation usually does not affect the point estimates of sensitivity and specificity. However, 
the interval estimates are problematic if the correlation is ignored since correlations are usually 
positive and thus inflate the variances. Currently, many methods are available to calculate 
confidence intervals (CIs) for sensitivity and specificity for binary data. Methods that ignore 
the correlations, such as the simple asymptotic method, the Clopper-Pearson method, the 
Wilson method, and the Agresti-Coull method, fail to account for the inflated variances and 
thus result in lower coverage probabilities [Agresti 1998, Clopper 1934, NEWCOMBE 1998, 
and Wilson 1927]. Alternative methods taking the binary correlations into consideration are 
available in the literature. Some non-parametric methods modify the simple asymptotic method 
by either adjusting the standard error with a ratio (SER) factor or a variance influence factor 
(VIF) or re-estimating the variance with a between-group variance (BGV) method [Fleiss 2003, 
Rao 1992, and Williams 2000]. There are also some parametric methods, such as the 
generalized linear mixed model (GLMM) and the generalized estimating equation (GEE), 
which work for correlated binary data. The GLMM assumes the binomial distribution for the 
data. Sensitivity and specificity, which are essentially binary proportions, are usually linked 
by a logistic function and estimated by conditioning on the random subjects [Mutsvari 2010]. 
The overall estimates of sensitivity and specificity are the medians of these subject-specific 
sensitivities and specificities, respectively. The GEE, which is used to implement a marginal 
model, requires a working correlation matrix for the correlations within the same subjects 
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[Smith 1992 and Zeger 1986]. The estimated sensitivity (and specificity) is the weighted 
average across all observations. 
All these methods developed for binary data theoretically apply to the continuous data 
since they can be dichotomized to binary data by a selected cutoff. However, there are two 
challenges for these methods: 1) If the true sensitivity or specificity are large, almost all tests 
might be positive or negative especially for small- to medium-sized data. This will result in 
CIs with width close to 0 for nonparametric methods and convergence problems for model-
based methods. 2) If different cutoffs are chosen, different converted binary data are obtained 
for different cutoffs. This will increase the burden of calculation if binary model-based 
methods are used. In this study, considering that most continuous clinical test data are normally 
distributed or normally distributed after transformation, we propose a new method based on 
the normal distribution to calculate the CIs of sensitivity and specificity for correlated and 
normally distributed observations. 
2.2 Method 
2.2.1 Model 
As discussed in the introduction section, in a typical biological clinical trial, multiple 
observations are often collected from each of many subjects. Since observations within the 
same subject tend to be correlated, a linear mixed model was assumed for data analysis:  
𝑌𝑖𝑗 = 𝜇 + 𝛾𝑖 + 𝜏𝑠𝑖𝑗 + 𝜖𝑖𝑗 
where 𝑌𝑖𝑗  is the 𝑗
th  observation for the 𝑖th  subject, 𝑖 = 1,2, … , 𝑃, 𝑗 = 1, 2, … , 𝑛𝑖 ; 𝜇  is the 
overall mean for the non-diseased (or healthy) group; 𝛾𝑖
′𝑠
𝑖𝑖𝑑
~
⁡
𝑁(0, 𝜎γ
2), where 𝛾𝑖 denotes the 
random effect of the 𝑖th subject; 𝜏, the mean difference between the diseased group and the 
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healthy group, is a fixed effect; 𝑠𝑖𝑗 = ⁡𝐼(𝑌𝑖𝑗⁡is⁡measured⁡from⁡the diseased⁡group) denotes 
the status of the  𝑗th observation for the 𝑖thsubject. Here 𝐼(∙) is the indicator function and 
defined as I(A) = 1 if and only if A is true. The 𝜖𝑖𝑗
indep
~
⁡
  𝑁(0, σes
2 ), where 𝜖𝑖𝑗 denotes the error 
term associated with the 𝑗th observation for the 𝑖th subject and 𝑠 ≜ 𝑠𝑖𝑗. Based on this model, 
we obtain the following means and covariances, 
𝐸(𝑌𝑖𝑗) = {
𝜇 ≜ 𝜇0
𝜇 + 𝜏 ≜ 𝜇1
healthy⁡(𝑠𝑖𝑗 = 0)
diseased⁡(𝑠𝑖𝑗 = 1)
 
Cov(𝑌𝑖𝑗, 𝑌𝑖‘𝑗’, ) = 𝜎γ
2𝐼(𝑖 = 𝑖′) + σes
2 𝐼(𝑖 = 𝑖′)𝐼(𝑗 = 𝑗′) 
 
= {
0 if 𝑖 ≠ 𝑖′
𝜎γ
2 + σes
2 ≜ 𝜎𝑠
2 = Var(𝑌𝑖𝑗) if 𝑖 = 𝑖
′,  𝑗 = 𝑗′
𝜎γ
2 otherwise
 
 
(2.1) 
Therefore, if (𝑖, 𝑗) ≠ (𝑖′, 𝑗′), 
 
(
𝑌𝑖𝑗
𝑌𝑖′𝑗′
)~MVN2 ((
𝜇𝑠
𝜇𝑠′
) , (
𝜎γ
2 + σes
2 𝜎γ
2𝐼(𝑖 = 𝑖′)
𝜎γ
2𝐼(𝑖 = 𝑖′) 𝜎γ
2 + σes′
2 )), (2.2) 
where 𝑠′ ≜ 𝑠𝑖′𝑗′.  
2.2.2 Estimates of sensitivity and specificity and their variances 
2.2.2.1 Point estimates of sensitivity and specificity 
In the following discussion, we assume the mean response of the diseased group to be 
larger unless specified. Sensitivity and specificity are abbreviated as Sen and Spe in 
mathematical expressions. For a specific cutoff c, the empirical estimates of sensitivity and 
specificity are defined as  
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 Sen̂ = ⁡∑∑𝐼(
𝑛𝑖
𝑗=1
𝑃
𝑖=1
𝑌𝑖𝑗 ≥ 𝑐)𝐼(𝑠𝑖𝑗 = 1)/𝑁𝑑 = ∑ ∑ 𝐼(
𝑑𝑖
𝑗𝑑=1
𝑃
𝑖=1
𝑌𝑖𝑗𝑑 ≥ 𝑐)/𝑁𝑑 (2.3) 
 Spê = ⁡∑∑𝐼(
𝑛𝑖
𝑗=1
𝑃
𝑖=1
𝑌𝑖𝑗 < 𝑐)𝐼(𝑠𝑖𝑗 = 0)/𝑁ℎ = ∑ ∑ 𝐼(
ℎ𝑖
𝑗ℎ=1
𝑃
𝑖=1
𝑌𝑖𝑗ℎ < 𝑐)/𝑁ℎ, (2.4) 
 
           
where 𝑁𝑑 , 𝑑𝑖, and⁡𝑗𝑑 are the total number of observations, the number of observations within 
subject i, and the index for the diseased group. And 𝑁ℎ , ℎ𝑖 = 𝑛𝑖 − 𝑑𝑖,  and 𝑗ℎ  are the 
corresponding terms for the healthy group. 
An alternative model-based estimates of sensitivity and specificity, denoted by “*”, are 
defined as 
 Sen̂∗ = Pr̂(𝑇 + |𝐷) = Pr̂(𝑌𝑖𝑗 > 𝑐|𝐷) = 1 − 𝛷 (
𝑐−?̂?1
?̂?1
), (2.5) 
 
where Pr̂(∙) denotes the probability calculated with respect to an estimated distribution for the 
diseased group, and 𝛷(∙) is the standard normal cumulative distribution function. Similarly, 
 Spê∗ = 𝛷 (
𝑐−?̂?0
?̂?0
). (2.6) 
 
The expected values of Sen̂ and Spê are 
𝐸(Sen̂) = ⁡∑ ∑ 𝐸(𝐼(
𝑑𝑖
𝑗𝑑=1
𝑃
𝑖=1
𝑌𝑖𝑗𝑑 ≥ 𝑐))/𝑁𝑑 = Pr⁡(𝑌𝑖𝑗𝑑 ≥ 𝑐) = Pr⁡(𝑇 + |𝐷) = Sen, 
𝐸(Spê) = ⁡∑ ∑ 𝐸(𝐼(
ℎ𝑖
𝑗ℎ=1
𝑃
𝑖=1
𝑌𝑖𝑗ℎ < 𝑐))/𝑁ℎ = Pr(𝑌𝑖𝑗ℎ < 𝑐) = Pr(𝑇 − |𝐻) = Spe. 
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Therefore, Sen̂ and Spê are unbiased estimators of sensitivity and specificity, no matter what 
the correlation is.  
2.2.2.2 Variances of 𝐒𝐞?̂? and 𝐒𝐩?̂? 
The derivations of the variances for Sen̂ and Spê are shown below: 
Var(Sen̂) = Var(⁡∑ ∑ 𝐼(
𝑑𝑖
𝑗𝑑=1
𝑃
𝑖=1
𝑌𝑖𝑗𝑑 ≥ 𝑐)/𝑁𝑑) 
= ⁡Var(⁡1 −∑ ∑ 𝐼(
𝑑𝑖
𝑗𝑑=1
𝑃
𝑖=1
𝑌𝑖𝑗𝑑 ≥ 𝑐)/𝑁𝑑) 
= Var(⁡∑ ∑ 𝐼(
𝑑𝑖
𝑗𝑑=1
𝑃
𝑖=1
𝑌𝑖𝑗𝑑 < 𝑐)/𝑁𝑑) 
=
1
𝑁𝑑
2 Var(∑ ∑ 𝐼(
𝑑𝑖
𝑗𝑑=1
𝑃
𝑖=1
𝑌𝑖𝑗𝑑 < 𝑐)) 
=
1
𝑁𝑑
2 Cov(∑ ∑ 𝐼(
𝑑𝑖
𝑗𝑑=1
𝑃
𝑖=1
𝑌𝑖𝑗𝑑 < 𝑐),∑ ∑ 𝐼(
𝑑𝑖
𝑗𝑑
′=1
𝑃
𝑖′=1
𝑌𝑖′𝑗𝑑′ < 𝑐)) 
=
1
𝑁𝑑
2 ⁡{𝐸 ([∑ ∑ 𝐼(
𝑑𝑖
𝑗𝑑=1
𝑃
𝑖=1
𝑌𝑖𝑗𝑑 < 𝑐)] [∑ ∑ 𝐼(
𝑑𝑖
𝑗𝑑
′=1
𝑃
𝑖′=1
𝑌𝑖′𝑗𝑑′ < 𝑐)]) − (𝐸 [∑ ∑ 𝐼(
𝑑𝑖
𝑗𝑑=1
𝑃
𝑖=1
𝑌𝑖𝑗𝑑 < 𝑐)])
2
} 
=
1
𝑁𝑑
2 {𝐸 [∑ ∑ 𝐼(
𝑑𝑖
𝑗𝑑=1
𝑃
𝑖=1
𝑌𝑖𝑗𝑑 < 𝑐)]} 
+
1
𝑁𝑑
2 ⁡{𝐸 [ ∑ 𝐼(𝑌𝑖𝑗𝑑 < 𝑐)𝐼 (𝑌𝑖𝑗𝑑′ < 𝑐) + ∑ 𝐼(𝑌𝑖𝑗𝑑 < 𝑐)𝐼 (𝑌𝑖′𝑗𝑑′ < 𝑐)
𝑖,𝑖′≠𝑖,𝑗𝑑,𝑗𝑑
′𝑖,𝑗𝑑,𝑗𝑑
′≠𝑗𝑑
]} 
⁡−⁡
1
𝑁𝑑
2 (𝑁𝑑⁡(1 − Sen))
2 
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=
1
𝑁𝑑
2 {𝑁𝑑(1 − Sen) + (∑[𝑑𝑖(𝑑𝑖 − 1)]
𝑖
)Pr (𝑌𝑖𝑗𝑑 < 𝑐, 𝑌𝑖𝑗𝑑′ < 𝑐)
+ (𝑁𝑑
2 − 𝑁𝑑 −∑[𝑑𝑖(𝑑𝑖 − 1)]
𝑖
) (1 − Sen)2} −⁡(1 − Sen)2 
=
1
𝑁𝑑
(1 − Sen) 
+
∑ [𝑑𝑖(𝑑𝑖 − 1)]𝑖
𝑁𝑑
2 Pr (𝑌𝑖𝑗𝑑 − 𝜇1 < 𝑐 − 𝜇1, 𝑌𝑖𝑗𝑑′ − 𝜇1
< 𝑐 − 𝜇1)⁡–⁡
𝑁𝑑 + ∑ [𝑑𝑖(𝑑𝑖 − 1)]𝑖
𝑁𝑑
2
(1 − Sen)2. 
 
Since (
𝑌𝑖𝑗𝑑
𝑌𝑖𝑗𝑑′
)~𝑀𝑉𝑁2 ((
𝜇1
𝜇1
) , (
𝜎1
2 𝜎𝛾
2
𝜎𝛾
2 𝜎1
2)), we have (
𝑌𝑖𝑗𝑑 − 𝜇1
𝑌𝑖𝑗𝑑′ − 𝜇1
)~𝑀𝑉𝑁2 ((
0
0
) , (
𝜎1
2 𝜎𝛾
2
𝜎𝛾
2 𝜎1
2)). 
Define 𝛴s = (
𝜎𝑠
2 𝜎𝛾
2
𝜎𝛾
2 𝜎𝑠
2)  and 𝑐𝑠 = c − 𝜇𝑠 , and let 𝐹𝑠(𝑥, 𝑦)  be the cumulative distribution 
function of 𝑀𝑉𝑁2 ((
0
0
) , 𝛴s) , 𝑠 = 0⁡or⁡1. Then 
Var(Sen̂) =
1
𝑁𝑑
(1 − Sen)
+
∑ [𝑑𝑖(𝑑𝑖 − 1)]𝑖
𝑁𝑑
2 𝐹1(𝑐1, 𝑐1)–⁡
𝑁𝑑 + ∑ [𝑑𝑖(𝑑𝑖 − 1)]𝑖
𝑁𝑑
2
(1 − Sen)2. 
(2.7) 
 
Similarly, 
Var(Spê) =
1
𝑁ℎ
(Spe) +
∑ [ℎ𝑖(ℎ𝑖 − 1)]𝑖
𝑁ℎ
2 𝐹0(𝑐0, 𝑐0)–⁡
𝑁ℎ + ∑ [ℎ𝑖(ℎ𝑖 − 1)]𝑖
𝑁ℎ
2
(Spe)2. (2.8) 
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The derivation above is based on the assumption of larger means for the diseased group. If, on 
the contrary, the healthy group possesses larger means, then formulas (2.7) and (2.8) would be 
modified as  
Var(Sen̂) =
1
𝑁𝑑
(Sen) +
∑ [𝑑𝑖(𝑑𝑖 − 1)]𝑖
𝑁𝑑
2 𝐹1(𝑐1, 𝑐1)–⁡
𝑁𝑑 + ∑ [𝑑𝑖(𝑑𝑖 − 1)]𝑖
𝑁𝑑
2
(Sen)2, (2.7a) 
 
Var(Spê) =
1
𝑁ℎ
(1 − Spe)
+
∑ [ℎ𝑖(ℎ𝑖 − 1)]𝑖
𝑁ℎ
2 𝐹0(𝑐0, 𝑐0)–⁡
𝑁ℎ + ∑ [ℎ𝑖(ℎ𝑖 − 1)]𝑖
𝑁ℎ
2
(1 − Spe)2. 
(2.8a) 
2.2.2.3 Interval estimates of sensitivity and specificity 
The most straightforward method to calculate the 95% CIs of sensitivity and specificity 
is 
 Sen̂ ± 𝑧1−𝛼/2√Var̂(Sen̂) (2.9) 
and  
 Spê ± 𝑧1−𝛼/2√Var̂(Spê), (2.10) 
where Var̂(Sen̂)⁡and⁡Var̂(Spê), the estimates of Var(Sen̂)⁡and⁡Var(Spê), are calculated by 
replacing the unknown parameters with their corresponding estimates; 𝑧1−𝛼/2  is the 
100 (1 −
𝛼
2
)% percentile of the standard normal distribution. 
However, these interval estimates of sensitivity and specificity might exceed the range 
of a probability, i.e., [0, 1].  To avoid this problem, we use the idea of transformation for 
constructing the CIs: 1) apply the logit-transformation to the estimates of sensitivity and 
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specificity, and 2) construct CIs for the logit-transformed Sen̂ and Spê. The variances of the 
transformed Sen̂ and Spê are derived by the delta method, as shown below 
 Var (logit(Sen̂)) =
Var(Sen̂)
[Sen(1 − Sen)]2
  
 
 Var (logit(Spê)) =
Var(Spê)
[Spe(1 − Spe)]2
.  
The 95% CIs for logit(Sen) and logit(Spe) are 
 logit(Señ) ± 𝑧1−𝛼/2√
Var̂∗(Sen̂)
[(Sen̂∗)(1 − Sen̂∗)]
2 (2.11) 
and 
 logit(Spẽ) ± 𝑧1−𝛼/2√
Var̂∗(Spê)
[(Spê∗)(1 − Spê∗)]
2, (2.12) 
where Var̂∗(Sen̂) and Var̂∗(Spê), similar to  Var̂(Sen̂)⁡and⁡Var̂(Spê), are another estimates 
of ⁡Var(Sen̂)⁡and⁡Var(Spê). The only difference is that Var̂∗(Sen̂) and Var̂∗(Spê) use the 
model-based estimates of sensitivity and specificity for calculation to avoid negative variances 
or infinite variances. For the point-estimates part of the CIs, the empirical estimates are 
preferred. However, as discussed by [Brown 2001], when very few (usually ≤ 5) observations 
are either below or above the cutoffs, the empirical point estimate of the proportion is 
unsuitable for calculating the CIs. In this case, the model-based point estimates are used. 
Therefore, in the point-estimates part of the CIs, 
 Señ ≜ {
Sen̂ if 5 < Number⁡of  (𝑇 + |𝐷) < 𝑁𝑑 − 5
Sen̂∗ otherwise
 
and  
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 Spẽ ≜ {
Spê if 5 < Number⁡of  (𝑇 − |𝐻) < 𝑁ℎ − 5
Spê∗ otherwise
. 
Finally, the interval estimates of sensitivity and specificity are obtained by back-transforming 
the CIs of the transformed sensitivity and specificity. 
2.3 Simulations 
The purpose of the simulation study is to evaluate if CIs calculated by the proposed 
method have reasonable coverage probabilities.  
2.3.1 Parameters 
We chose 30 subjects for the simulation, with 21 observations from each of the subjects. 
Among these subjects, P1 (= 5) subjects were always healthy and data from these subjects were 
considered from the healthy group. For the other P2 (= 25) subjects, n21 (= 3) observations were 
collected from each subject when the subjects were healthy while the other n22 (= 18) were 
collected when the subjects were infected. The parameters for the simulation were chosen as 
𝜇0 = 0;⁡𝜇1 = −0.8;⁡𝜎𝛾
2 = 0.01, 0.1, 0.5; 𝜎𝑒0
2 = 0.02; 𝜎𝑒1
2 = 0.1 . For each combination of 
these parameters, 10,000 datasets were simulated. Sensitivity and specificity were calculated 
w.r.t cutoff = (−0.8, −0.6, −0.4, −0.2, 0). The simulated data and the following real data were 
both analyzed by a linear mixed model package in R (R: nlme). 
2.3.2 Results and discussion 
2.3.2.1 Estimates of standard errors of 𝐒𝐞?̂? and 𝐒𝐩?̂? 
Since in the simulated data the non-diseased group possessed a larger mean, formulas 
(2.7 a) and (2.8 a), instead of formulas (2.7) and (2.8), were used to calculate the standard 
errors of Sen̂ and Spê. The averaged standard errors were calculated by averaging the standard 
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errors over 10,000 simulations. The standard errors were also estimated by the simple 
asymptotic method and averaged over 10,000 simulations. The theoretical standard errors were 
calculated by plugging in the true parameters into (2.7 a) and (2.8 a). The plots of all the 
standard errors are shown in Figure 2.1. Note that the standard errors estimated by the proposed 
method are very close to the true values while the standard errors estimated by the simple 
asymptotic method are significantly below the true values, especially for large covariances. 
2.3.2.2 Coverage Probabilities 
From each combination of the selected cutoffs and the other simulation parameters, 
10,000 95% CIs of sensitivity and specificity were calculated from 10,000 simulations by 
following the procedure discussed in Section 2.2. The coverage probability (CP) is the 
probability of the calculated CIs covering the true value. The true values of sensitivity and 
specificity are calculable by replacing estimates of model parameters with the true parameters 
in formulas (2.5) and (2.6). The CPs of the CIs calculated by the proposed method and the 
existing methods mentioned in the introduction are plotted in Figure 2.2. Note that several 
methods can be used to calculate CIs with correlations ignored. We use the Clopper-Pearson 
method because it is conservative. 
Figure 2.2 shows that the proposed method (red solid lines with hollow circular 
symbols) outperforms all of the existing methods. The CP calculated using the method with 
correlations ignored is significantly below 95% because it fails to account for the inflated 
variation introduced by the correlation. The GLMM doesn’t perform well for data with a large 
enough intra-subject correlation (covariance ≥ 0.1). The GEE, on the contrary, performs well 
except when the sensitivity or specificity is extremely close to 1. However, both of the two 
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Figure 2.1. Plots of the averaged estimates of standard errors and theoretical standard errors: solid lines denote 
theoretical values; dashed lines denote the averaged estimates from the proposed method; dotted lines denote 
averaged estimates from the simple asymptotic method. 
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current model-based methods suffer from convergence problems and many CPs showed in 
Figure 2.2 are calculated based on part of the simulated datasets. Table 2.1 shows the number 
of converged analyses out of the total number of simulated data. From Table 2.1, we observe 
that both extreme values of sensitivity or specificity and large correlations (given similar values 
of sensitivity and specificity) are detrimental to the convergence for the GEE method. And 
there are more non-convergences for the GLMM. When the covariance is 0.01 and the cutoff 
is −0.8, there are only five converged analyses for the calculation of the CP of specificity. This 
is because with these parameter values, the specificity is 0.999981 and the probability that all 
of the 180 simulated clinical test results in the healthy group are negative is 99.966%. 
As for the non-parametric method, when the numbers of observations from each subject 
are not too small, just like the simulated data in the diseased group, the three non-parametric 
methods, VIF, SER and BGV, work well and have similar CPs. However, as the magnitude of 
sensitivity or specificity gets close to 1 or the covariance increases, the CPs decrease. On the 
other hand, when most of subjects don’t have many observation, like the healthy group, the 
CPs of VIF and SER decrease significantly from the nominal value, especially when 
covariance is large or the sensitivity or the specificity is extremely large in magnitude. The 
BGV is very conservative and the CPs tend to be larger than the nominal value. 
The CPs calculated with the proposed method are very close to the nominal value 95% 
and only slightly positively biased when sensitivity or specificity is above ~90%. Besides the 
reasonable CPs, another advantage of the proposed method over current model-based methods 
is that a new cutoff does not create a new dataset, which means that we need not re-analyze 
the data for a new cutoff value. This is important when performing large volumes of 
simulations with different cutoff values. 
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Figure 2.2. Coverage probabilities of 95% CIs of sensitivity and specificity from the simulation study. Solid lines 
with different symbols denote different methods. The dashed black line is the nominal CP(= 95%).  
17 
 
Table 2.1. The number of converged analyses out of 10,000 simulations for different sensitivity and specificity 
values (round to 4 decimal places) 
Cutoff −0.8 −0.6 −0.4 −0.2 0 
S
en
si
ti
v
it
y
 
Cov
= 0.01 
True value 0.5 0.7268 0.8861 0.9648 0.9921 
GLMM 10000 10000 8831 9968 9688 
GEE 10000 10000 10000 10000 9688 
Cov
= 0.1 
True value 0.5 0.6726 0.8145 0.9101 0.9632 
GLMM 10000 9817 9016 9752 9496 
GEE 10000 10000 10000 10000 9980 
Cov
= 0.5 
True value 0.5 0.6019 0.6972 0.7807 0.8492 
GLMM 9557 9530 9448 9438 9542 
GEE 10000 10000 10000 10000 10000 
S
p
ec
if
ic
it
y
 
Cov
= 0.01 
True value 1 0.9997 0.9895 0.8759 0.5 
GLMM 5 451 7621 9762 9929 
GEE 5 458 7796 10000 10000 
Cov
= 0.1 
True value 0.9895 0.9584 0.8759 0.7181 0.5 
GLMM 5365 9188 9483 9350 9217 
GEE 5504 9369 9997 10000 10000 
Cov
= 0.5 
True value 0.8664 0.7973 0.7105 0.6092 0.5 
GLMM 9624 9633 9601 9403 9293 
GEE 9981 9999 10000 10000 10000 
 
2.4 Application 
2.4.1 Data collection 
The real data were collected from a study on the influenza A virus (IAV) in swine. 
Animals in this study were chosen from a commercial farm in which there were about 600 
breeding females [Panyasing 2014]. Approximately 21-day-old piglets were weaned, ear- 
tagged, and quarantined in one room. The piglets were randomly assigned to 6 treatments by 
assigning ear tags to treatments randomly. The treatments were the combinations of inoculation 
(None, H1N1 and H3N2) and vaccination (Yes and No), where H1N1 and H3N2 are two 
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subtypes of IAV. Vaccination was given to the piglets on the day post inoculation (DPI) −42 
and −21. On DPI −10, they were shipped to Iowa State University and the piglets with the 
same treatments were grouped into several pens. On DPI 0, the piglets received either H1N1 
or H3N2 inoculation. Oral fluid samples were collected weekly at DPI = 0, 7, 14, 21, 28, 35, 
and 42 from each pen. Thus samples could be identified to the pen level. Antibodies were 
measured by NP-blocking-ELISA with 3 technical repeats for each sample. Samples, as well 
as the positive controls and negative controls, were measured in plates. Positive and negative 
controls are used for the quality control, which are expected to provide outputs within certain 
ranges. If either the negative control or the positive control or both provides an output out of 
the range, the plate is invalid and the samples in the same plate need to be re-tested. The sample 
to negative (S/N) is the response, which is defined as 
 𝑆/𝑁 =
Sample − Positive control̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅
Negative control̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅ − Positive control̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅
. 
A separate statistical analysis [Panyasing 2014] showed that 1) vaccination did not make any 
significant difference; 2) there was no significant difference between the two subtypes of IAV. 
Therefore, vaccination is excluded from our data analysis and H1N1 and H3N3 are combined 
as “Yes” for inoculation. 
Totally, samples were collected from 26 pens. Piglets from 4 of the 26 pens did not 
receive any inoculations while piglets from the other 22 pens received either H1N1 or H3N2 
inoculation. Totally, there were 3 (repeats) × 7 (DPI) = 21 observations from each pen. The 
logarithm of S/N was considered as the response so that the distribution of the response was 
more symmetric. To estimate the sensitivity and specificity, the population was divided into 
two groups: the non-diseased group and the diseased group. The observations from the non-
diseased group had two sources: 1) samples collected from pens which did not receive any 
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inoculation; 2) samples collected when DPI = 0 even if the piglets in the pen were inoculated. 
The rest were classified as from the diseased group.  Therefore, the non-diseased samples were 
collected from 26 pens, 4 of which were sampled 7 × 3 times while the other 22 were sampled 
3 times. In the diseased group, there were 22 pens, each of which were sampled 6 × 3 times. 
2.4.2 Results 
The real data was analyzed by the linear mixed model and the point estimates of model 
parameters were: ?̂?0 = −0.06, ?̂?1 = −0.86, ?̂?𝛾 =⁡0.11, ?̂?𝑒0 =⁡0.15 and ?̂?𝑒1 =⁡0.33. The cutoff 
values were selected so that the sensitivity or specificity could reach desired values. In this 
paper, the empirical estimate of specificity was set to be 0.9 and 0.95. The corresponding cutoff 
values, the point estimates and CI’s (keeping 3 decimal digits) of sensitivity and specificity for 
the real data were calculated and shown in Table 2.2. 
2.5 Conclusion 
The method proposed in this study provides a new way to calculate the CIs of 
sensitivity and specificity for correlated and normally distributed data. In the new method, 
variances of Sen̂ and Spê are calculated based on the multi-variate normal distribution. The 
logit transformation and the corresponding back-transformation are applied to ensure the range 
of the calculated CIs is limited to [0,1]. From the simulation, the CIs calculated using the 
proposed method overall have more reasonable CPs (close to 95% if the significance level is 
0.05) than the CIs from the current methods. Moreover, the proposed method reduces the risk 
of the convergence problem and doesn’t require re-analysis of data if we choose different cutoff 
values. This is an important advantage over current binary model-based methods, especially 
when performing high volumes of simulations with different cutoff values. 
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Table 2.2. The estimates and 95% CIs of sensitivity and specificity of the real data calculated by the proposed 
method and the existing method. 
cutoff −0.235 −0.356 
Specificity Empirical Estimate 0.900 0.947 
CI Proposed (0.805, 0.952) (0.848, 0.983) 
Clopper-Pearson (0.840, 0.943) (0.898, 0.977) 
Wilson (0.842, 0.938) (0.898, 0.973) 
Simple Asymptotic (0.852, 0.948) (0.911, 0.983) 
Agresti-Coull (0.840, 0.939) (0.896, 0.974) 
SER (0.808, 0.992) (0.889, 1.000) 
VIF (0.810, 0.990) (0.890, 1.000) 
BGV (0.444, 1.000) (0.501, 1.000) 
GLMM (0.991, 1.000) (0.977, 1.000) 
GEE (0.841, 0.939) (0.897, 0.973) 
Sensitivity Empirical Estimate 0.949 0.919 
CI Proposed (0.912, 0.972) (0.878, 0.947) 
Clopper-Pearson (0.923, 0.969) (0.888, 0.944) 
Wilson (0.923, 0.967) (0.888, 0.942) 
Simple Asymptotic (0.928, 0.971) (0.892, 0.946) 
Agresti-Coull (0.923, 0.967) (0.888, 0.942) 
SER (0.918, 0.981) (0.880, 0.958) 
VIF (0.919, 0.980) (0.881, 0.957) 
BGV (0.919, 0.980) (0.881, 0.957) 
GLMM (0.926, 0.991) (0.892, 0.969) 
GEE (0.923, 0.967) (0.888, 0.942) 
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CHAPTER 3.    A BAYESIAN MODEL FOR CLUSTERED 
DATA WITH LATENT VARIABLES 
Abstract: The evaluation of new diagnostic tests for diseases are challenging, 
especially when the true statuses are uncertain. For example, an enzyme-linked immunosorbent 
assay (ELISA) test detects and measures antibodies in blood, but not all diseased subjects will 
have obvious antibody reaction when exposed to certain antigens. In this study, we proposed 
a Bayesian hierarchical model for estimation of sensitivities and specificities of 6 new 
diagnostic tests measured on the same subjects. We use latent variables to indicate the antibody 
reaction statuses, which are not known for sure. Simulation studies show that our model 
provides accurate estimates of the model parameters and sensitivities and specificities of the 
diagnostic tests. 
3.1 Introduction 
As discussed in Section 1.1, sensitivity and specificity are building bricks of an ROC 
curve which is an important statistical method to evaluate and compare binary tests. Sensitivity, 
also known as the true positive rate, is the proportion of positive tests within the diseased group. 
Similarly, specificity, known as the true negative rate, is the proportion of negative tests within 
the non-diseased group. If the statuses of subjects are known, the sensitivity and specificity are 
estimable by the empirical method. However, in many clinical tests, the true statuses of the 
subjects are unknown. In this situation, the empirical method will fail and the model-based 
method is the only way to estimate the sensitivity and specificity. Given a cutoff (or threshold) 
value that separates positive and negative tests, and under the assumption that observations in 
the diseased group tend to possess larger values, the model-based estimates of sensitivity and 
specificity are defined in formulas (2.5 – 2.6) in Chapter 2. Estimating the model parameters, 
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which is required for the model-based estimates of sensitivity and specificity, tends to be 
challenging because of 1) intra-subject correlation; 2) unknown subject status. For example, in 
a clinical test, if a person gets infected with some virus, the counts of some of the relevant 
antibodies might increase to fight the virus. However, the types of antibodies that increase in 
counts might be different for different patients. 
Methods to analyze clustered data have been developed for decades and well described 
[Galbraith 2010]. [Dunson 2000] incorporated latent variables to analyze mixed outcomes. The 
latent variables, either assumed to be normally distributed or linked to variables that followed 
a simple exponential family, were used to control correlations between observations. However, 
the model parameters are not complicated enough to solve the problems discussed in this paper. 
In our study, the antibody statuses of observations are unknown and are modeled by a latent 
variable. We use the Bayesian method combined with Markov chain Monte Carlo (MCMC) to 
make inference for the model parameters [Gelman 2004, Gilk 1996, and Robert 2004].  
3.2 Data 
3.2.1 Data Collection 
The data were collected in a veterinary clinical study. In this study, 24 14-week old 
pigs (subjects) were randomly assigned to 4 groups to receive Actinobacillus 
pleuropneumoniae (APP) with serovars 1, 5, 7 or 12 by blindly selecting ear tags from a bag, 
with 6 pigs per group. Serum samples were collected weekly and oral fluid samples were 
collected daily till the 56th day post inoculation (DPI). Antibodies were tested using enzyme-
linked immunosorbent assay (ELISA) tests. Totally, seven antibodies (“Serum-
S/P_ApxIV_IgG”, “Serum-S/P_ApxIV_IgM”, “Serum-S/P_ApxIV_IgA”, “APP.1(9,11)-
ELISA”, “5a,5b_LPS_ELISA”, “7(4)_LPS_ELISA”, and “12_LPS_ELISA”) from the serum 
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samples and three antibodies (“S/P_IgG”, “S/P_IgM”, and “S/P_IgA”) from the oral fluid 
samples were tested. 
3.2.2 Data properties 
All the 24 pigs were healthy initially and got infected because of the inoculation that 
would stimulate some antibody to fight against the virus. Figure 3.1 shows the observations 
for pig 77 and pig 78 that were both inoculated with the virus with serotype 1.  
 
Figure 3.1. Observations of all antibodies for pig 77 (left) and pig 78 (right): different colors denote different 
antibodies. 
From Figure 3.1, we observed the following. 1) All of the antibodies from both pigs 
stayed at the baseline for day<0, indicating that both pigs were noninfected initially. 2) After 
the inoculation, in both pigs, the counts of some of the antibodies increased dramatically from 
the baseline and reached to much higher levels. Here, a new binary variable, named antibody 
status, was introduced and it could be either normal (at the baseline) or abnormal (at the higher 
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level). 3) For the infected pigs, antibodies that showed abnormality were random: the antibody 
denoted by the dark green curve showed abnormality in pig 78, but remained at the normal 
status in pig 77. 
Figure 3.2 shows the observations of the antibody named “S/P_IgG” from all the pigs. 
 
Figure 3.2. Observations of the antibody named “S/P_IgG” from all the pigs: different colors denote different 
pigs. 
From Figure 3.2, we observed that for the antibody, the variances of observations were 
different for different antibody statuses: the abnormal antibodies, with higher values, possessed 
larger variances.  
This paper proposes a normal-distribution-based hierarchical model with the latent 
status. We use the Bayesian method together with MCMC to analyze the data.  
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3.3 Method 
3.3.1 Model 
During the process of model building, some facts discussed previously were taken into 
consideration: 1) For the infected pigs, some (not necessarily all) of the antibodies would show 
abnormality and the antibodies that showed abnormality might be different for different 
infected pigs. 2) The standard errors were heterogeneous for different antibodies and different 
antibody statuses. Besides these facts, three assumptions were made for this model: 1) Data (or 
transformed data) were normally distributed; 2) Observations of the same pig were correlated. 
3) Once an antibody reached the abnormal status, the antibody would stay at the abnormal 
level. In this study, the observations for an antibody given a certain pig might have different 
statuses at different time points, i.e., initially normal and then abnormal sometime after the 
inoculation. This would increase the complexity of the model. Because the change of a certain 
antibody over time was not our point of interest, data were truncated and those with DPI<20 
were excluded for analysis. For the truncated data, observations of the same pig and the same 
antibody roughly stayed at either the normal status or the abnormal status throughout the rest 
of the time.  
We also observed that no antibody was stimulated to fight against the virus for some 
pigs that were inoculated with the virus with serotype 12, which might be indicative of a 
different population. In this study, all pigs in the group of serotype 12 were excluded for data 
analysis.  
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Let 𝑌𝑖𝑙𝑗𝑘  denote the measurement of the k
th antibody measured from the ith pig that 
received the lth serotype on the jth day , 𝑖 =1, 2,…, 6; 𝑗=21, 22,…, 56; 𝑘=1, 2,…, 10; 𝑙 =1, 2, 
and 3. Based on these facts and assumptions, we proposed the following model: 
𝑌𝑖𝑙𝑗𝑘 = 𝛽0𝑘 + 𝛽1𝑘𝑆𝑖𝑙𝑘 + (𝑧𝑖𝑙 + 𝜀𝑖𝑙𝑗𝑘)𝜎𝑆,𝑘, 
where 
𝑆𝑖𝑙𝑘
indep
~
⁡
Bernoulli(𝑃𝑘𝑙) 
and 𝛽0𝑘 is the mean of the k
th antibody if it is at the level of normality while 𝛽1𝑘 is the mean 
difference between the abnormal level and the normal level for the kth antibody; 𝑃𝑘𝑙 denotes 
the probability of the kth antibody to reach the abnormal level for pigs inoculated with the virus 
of the serotype l; 𝑆𝑖𝑙𝑘 denotes the status (0 for the normal level and 1 for the abnormal level) 
of the kth antibody for the ith pig that received virus with serotype l; 𝑧𝑖𝑙
iid
~
⁡
𝑁(0, 𝜌)  and 
𝜀𝑖𝑙𝑗𝑘
iid
~
⁡
𝑁(0,1 − 𝜌) are random effects to account for intra-subject (pig) correlation and random 
error, respectively, where 𝜌 denotes the correlation of observations within the same pig; 𝜎𝑆,𝑘, 
an unknown constant, denotes the standard deviation (sd) of the kth antibody at level S. Note: 
in the following context, I will call the ith pig that received the lth serotype as the (𝑖𝑙)th pig. 
From this model, we have that 
𝜇𝑖𝑙𝑘 ≜ 𝛽0𝑘 + 𝛽1𝑘𝑆𝑖𝑙𝑘
= {
𝛽0𝑘
𝛽0𝑘 + 𝛽1𝑘
if⁡the⁡𝑘thantibody⁡of⁡the⁡(𝑖𝑙)thpig⁡is⁡at⁡the⁡normal⁡status
otherwise
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cov(𝑌𝑖𝑙𝑗𝑘, 𝑌𝑖‘𝑙‘𝑗‘𝑘‘|𝑆𝑖𝑙𝑘，𝑆𝑖‘𝑙‘𝑘‘)
= 𝜌𝜎𝑆𝑘𝜎𝑆′𝑘′𝐼(𝑖 = 𝑖
′) + (1 − 𝜌)𝜎𝑆𝑘𝜎𝑆′𝑘′𝐼(𝑖 = 𝑖
′)𝐼(𝑗 = 𝑗′)𝐼(𝑘 = 𝑘′)
= {
0 for⁡different⁡pigs
𝜌𝜎𝑆𝑘𝜎𝑆′𝑘′ for⁡the⁡same⁡pig⁡but⁡either⁡different⁡antibodies⁡or⁡different⁡times
𝜎𝑆𝑘
2 for⁡the⁡same⁡pig, antibody, and⁡time⁡
 
Because of the complexity of this hierarchical model, the likelihood function was hard 
to obtain. Thus, the Bayesian method was used during the process of data analysis. Because 
we didn’t have enough information for model parameters, non-informative priors were 
assigned [Gelman 2004, Gelman 2006, Huang 2013, and Kerman 2011]:  
𝛽0𝑘~𝑁(0, 1000) 
𝛽1𝑘~𝑁(0, 1000)𝐼(0, +∞) 
𝜎𝑆,𝑘~unif(0, 100) 
𝑃𝑘,𝑙~Beta(0.5, 0.5) 
𝜌~unif(−1, 1) 
3.3.2 Method to determine the cutoff 
Once we have parameter values, the cutoff values are determined by a desired value of 
either sensitivity or specificity. In this study, the true status is the antibody status. Therefore, 
sensitivity and specificity can be calculated with respect to the antibody status, and the 
inversion of the formula for sensitivity or the specificity can be used to calculate the cutoffs. 
If the kth antibody from the (𝑖𝑙)th  pig was at the abnormal status, i.e., 𝑆𝑖𝑙𝑘=1, then the 
observations for this antibody would follow a normal distribution with mean = 𝛽0𝑘 + 𝛽1𝑘 and 
sd = 𝜎1𝑘, i.e., 
𝑌𝑖𝑙𝑗𝑘 ~ N(𝛽0𝑘 + 𝛽1𝑘,⁡𝜎1𝑘
2 ). 
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Alternatively, if an antibody was at the normal status, i.e., 𝑆𝑖𝑙𝑘=0, then the observations for this 
antibody would follow a normal distribution with mean = 𝛽0𝑘 and sd = 𝜎0𝑘, i.e., 
𝑌𝑖𝑙𝑗𝑘 ~ N(𝛽0𝑘,⁡𝜎0𝑘
2 ). 
Therefore, for the kth antibody, given a desired value of sensitivity or specificity, denoted by 
Sen̂k and Spêk, the cutoff is calculated by one of the two following two methods: 
Sen̂k = Pr̂(𝑌𝑖𝑙𝑗𝑘 > 𝑐𝑘|𝑆𝑖𝑙𝑘 = 1) 
= Pr̂(𝑌𝑖𝑙𝑗𝑘 − ?̂?0𝑘 − ?̂?1𝑘 > 𝑐𝑘 − ?̂?0𝑘 − ?̂?1𝑘|𝑆𝑖𝑙𝑘 = 1) 
= 1 − 𝛷 (
𝑐𝑘 − ?̂?0𝑘 − ?̂?1𝑘
?̂?1𝑘
). 
Therefore, 
𝑐𝑘 = 𝑄(1 − Sen̂k) ∙ ?̂?1𝑘 + ?̂?0𝑘 + ?̂?1𝑘, 
where 𝛷(. ) and Q(.) are the cumulative distribution function and quantile function of N(0, 1). 
Similarly,  
Spêk = Pr̂(𝑌𝑖𝑙𝑗𝑘 < 𝑐𝑘|𝑆𝑖𝑙𝑘 = 0) 
= Pr̂(𝑌𝑖𝑙𝑗𝑘 − ?̂?0𝑘 < 𝑐𝑘 − ?̂?0𝑘|𝑆𝑖𝑙𝑘 = 0) 
= 𝛷(
𝑐k − ?̂?0𝑘
?̂?0𝑘
). 
And 
𝑐𝑘 = 𝑄(Spêk) ∙ ?̂?0𝑘 + ?̂?0𝑘 
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3.4 Results 
3.4.1 Convergence 
Since some antibodies stayed at the normal status all the time for all the pigs and 
couldn’t provide enough information about the difference between the two antibody statuses, 
only six antibodies (“S/P_IgG”, “S/P_IgM”, “S/P_IgA”, “APP.1(9,11)-ELISA”, 
“5a,5b_LPS_ELISA”, and “7(4)_LPS_ELISA”) were chosen for data analysis. The data were 
analyzed with R: rjags. Two Markov chains were used for the MCMC algorithm. First, 100,000 
iterations were used for the burn-in process. Then another 100,000 iterations were used for 
sampling, which reflected the posterior distributions of the parameters. The trace-plots of the 
100,000 samples from the posterior distributions of some key parameters were made. Figure 
3.3 shows the trace-plots of the sampled β1’s only. 
Visual inspection of the trace-plots showed that the sampled β1’s from the two Markov 
chains roughly converge to the same distributions. The Gelman-Rubin diagnostic [Brooks 
1998 and Gelman 1992] was applied to the samples of all key parameters. The Gelman-Rubin 
diagnostic is mainly used to test the convergence of multiple Markov chains. For univariate 
diagnostic, the variance within chains, denoted by W, and the variance between chains, denoted 
by B, are calculated first. The overall variance, denoted by V, is the weighted average of B and 
W. It assesses whether the difference between V and W is large enough to be a concern. The 
Gelman-Rubin statistic, called the potential scale reduction factor (PSRF), is defined as  
?̂? = √
𝑉
𝑊
. 
 
30 
 
Figure 3.3. Trace-plots of the sampled β1’s 
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If ?̂? is larger than 1.1, it is a concern. From the univariate test, the maximum of the 
upper limit of CIs of R’s is 1.01. The PSRF of the multivariate Gelman-Rubin diagnostic 
[Brooks 1998] turned out to be 1. Therefore, based on either the univariate or the multivariate 
Gelman-Rubin diagnostic, the MCMC sampling process converged. 
3.4.2 Estimates of model parameters 
The model parameters were estimated by the sample means and credible intervals (c.i.’s) 
obtained from the posterior distributions. Table 3.1 shows the estimates of the key parameters 
(means, variances, and correlation coefficient) that were useful for evaluating sensitivity and 
specificity or justifying assumptions when establishing the model.  
Table 3.1. Point estimates and 95% c.i.’s of the key model parameters. 
Parameter 𝛽01 𝛽02 𝛽03 𝛽04 𝛽05 𝛽06 𝛽11 𝛽12 𝛽13 
Estimate 0.035 0.052 0.142 0.051 0.036 0.04 0.363 0.123 0.208 
c.i. 0.016 
~ 
0.056 
0.033  
~  
0.072 
0.109  
~  
0.178 
0.039  
~  
0.064 
0.031 
~ 
0.041 
0.032  
~  
0.048 
0.269 
~ 
0.463 
0.046 
~  
0.206 
0.045  
~ 
0.379 
Parameter 𝛽14 𝛽15 𝛽16 𝜎01 𝜎02 𝜎03 𝜎04 𝜎05 𝜎06 
Estimate 0.877 0.401 0.915 0.062 0.062 0.111 0.035 0.014 0.023 
c.i. 0.747 
~ 
1.007 
0.339  
~  
0.471 
0.882  
~  
0.946 
0.052  
~  
0.085 
0.051  
~  
0.085 
0.094  
~  
0.151 
0.027 
~  
0.049 
0.011 
~ 
0.02 
0.018  
~  
0.033 
Parameter 𝜎11 𝜎12 𝜎13 𝜎14 𝜎15 𝜎16 𝜌 𝑃11 𝑃21 
Estimate 0.37 0.306 0.607 0.332 0.168 0.086 0.383 0.75 0.372 
c.i. 0.312  
~  
0.502 
0.254  
~  
0.417 
0.5 
~  
0.828 
0.242  
~  
0.483 
0.125  
~  
0.241 
0.062  
~  
0.125 
0.197  
~  
0.676 
0.372 
 ~ 
0.977 
0.051  
~ 
0.77 
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Table 3.1 continued 
Parameter 𝑃31 𝑃41 𝑃51 𝑃61 𝑃12 𝑃22 𝑃32 𝑃42 𝑃52 
Estimate 0.25 0.916 0.084 0.083 0.214 0.499 0.071 0.071 0.929 
c.i. 0.022  
~ 
0.63 
0.62 
~ 
1 
0 
~  
0.381 
0 
~  
0.379 
0.019  
~  
0.557 
0.166  
~  
0.833 
0  
~  
0.331 
0  
~  
0.329 
0.671  
~  
1 
Parameter 𝑃62 𝑃13 𝑃23 𝑃33 𝑃43 𝑃53 𝑃63   
Estimate 0.072 0.917 0.417 0.75 0.084 0.071 0.928   
c.i. 0  
~  
0.334 
0.622  
~  
1 
0.094  
~  
0.79 
0.372  
~  
0.978 
0  
~  
0.381 
0  
~  
0.329 
0.669  
~  
1 
  
 
From Table 3.1, we observed the following. 1) For all antibodies, the variances at the 
abnormal status were ~5-10 times as large as those at the normal status, which indicated that 
the heterogeneous variance assumption for different antibody statuses was reasonable. 2) The 
estimated correlation coefficient ?̂? = 0.38 and the c.i.= (0.2, 0.68) confirmed the existence of 
the correlation between observations from the same subject. A follow-up question was that: 
“within the same subject, is it possible that observations from the same antibody are more 
correlated than those from different antibodies?” That was possible. However, given the 
limited number of subjects, it was not worth introducing heterogeneous correlations for 
different antibodies. Thus, this estimated correlation could be viewed as an averaged 
correlation for all antibodies within the same subject. We also observed that the 4th – 6th serum 
antibodies, “APP.1(9,11)-ELISA”, “5a,5b_LPS_ELISA”, and “7(4)_LPS_ELISA”, were 
significantly responsive to infections corresponding to serovars 1, 5, and 7, respectively with  
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𝑃𝑗+3,𝑗 > 90%, 𝑗 = 1, 2, and⁡3. However, the cross responses of serum antibodies to serovars 
were very low with 𝑃𝑖𝑗 < 10%, 𝑗 = 1, 2, and⁡3; 𝑖 ≥ 4⁡and⁡𝑖 ≠ 𝑖 + 3. The responses of oral 
fluid antibodies to the different infections were also quite different with most stimulation rates 
varying between 21.4% and 75%, and very few (=2) rates <10% or >90%. 
Cutoff values were calculated from each of the sampled parameter values by following 
the discussion in Section 3.3 and thus could be considered “sampled” cutoffs. The point 
estimates and c.i.’s of the cutoffs w.r.t  sen̂ = 90% were calculated by the means and the 2.5% 
- 97.5% percentiles of the “sampled” cutoffs and were shown in Table 3.2. An alternative way 
for the point estimates of cutoffs is to calculate the cutoffs based on the estimated model 
parameters. The point estimates of cutoffs calculated by these two methods turned out to be 
identical if we kept two decimal digits. 
Table 3.2. Point estimates and 95% c.i.’s of the cutoffs for the six antibodies. 
Parameter 𝑐1 𝑐2 𝑐3 𝑐4 𝑐5 𝑐6 
Estimate −0.076 −0.216 −0.43 0.502 0.221 0.845 
c.i. −0.292  
- 
 0.054 
−0.396  
-  
−0.107 
−0.794  
- 
−0.193 
0.244  
-  
0.676 
0.108  
- 
 0.296 
0.774  
- 
 0.893 
 
Figure 3.4 shows the distributions of the six antibodies as well as the cutoff values 
determined with respect to a 90% sensitivity. From Figure 3.4, we observed that the abnormal 
data and the normal data were clearly separated for the serum antibodies (“APP.1(9,11)- 
ELISA”, “5a,5b_LPS_ELISA”, and “7(4)_LPS_ELISA”), which made it possible to achieve 
large sensitivity and specificity simultaneously. Furthermore, the majority of the data at the 
normal level were distributed below the cutoff values, which led to specificity close to 1. On 
the contrary, for the oral fluid antibodies, the differences between the normal data and the 
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abnormal data were shaded by the comparably-sized variances, making it hard to obtain large 
sensitivity and specificity simultaneously. Therefore, from the perspective of clinical testing, 
antibodies from the serum samples were better choices.  
 
 
Figure 3.4. Plots of the probability density function (PDF) for the six antibodies: the solid black lines denote the 
PDF for the normal level; the dashed lines denote the PDF for the abnormal level; the dotted lines denote the 
determined cutoff values to achieve 90% sensitivity. 
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3.5 Simulations 
Accurately estimated parameters are important for estimating the distributions of 
response variables and thus the cutoff values for given values of sensitivity or specificity. To 
evaluate how accurate the proposed method can recover the true parameters, we applied this 
method to simulated data. There were six response variables in the simulated data. The first 
three were sampled “daily” and there were 35 sampled values on each subject for these 
antibodies. The other three response variables were sampled “weekly” and had 5 values on 
each subject. These six response variables were mimics of antibodies from the oral fluid and 
serum samples. The parameters for simulations were chosen to be in a similar range of the 
estimated parameters from the real data and are shown in Table 3.3. Note that 𝛽0’s were all 
chosen to be 0 since they don’t influence the relative magnitudes between sensitivity and 
specificity.  
Table 3.3. True parameters for simulations 
Parameter 𝛽01 𝛽02 𝛽03 𝛽04 𝛽05 𝛽06 𝛽11 𝛽12 
True value 0 0 0 0 0 0 0.15 0.3 
Parameter 𝛽13 𝛽14 𝛽15 𝛽16 𝜎01 𝜎02 𝜎03 𝜎04 
True value 0.45 0.6 0.75 0.9 0.05 0.05 0.05 0.05 
Parameter 𝜎05 𝜎06 𝜎11 𝜎12 𝜎13 𝜎14 𝜎15 𝜎16 
True value 0.05 0.05 0.3 0.3 0.3 0.3 0.3 0.3 
Parameter 𝜌 𝑃𝑘𝑙  
𝑘 ≤ 3, 𝑙 ≤ 3  
𝑃𝑘𝑙  
6 ≥ 𝑘 > 3, 
⁡𝑙 = 𝑘 − 3 
𝑃𝑘𝑙  
6 ≥ 𝑘 > 3, 
⁡𝑙 ≠ 𝑘 − 3⁡&⁡𝑙 ≤ 3 
True value 0.4 0.5 0.9 0.1 
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The number of subjects (pigs) was chosen to be either 18 (3 serotypes ×  6 
subjects/serotype) or 180 (3 serotypes × 60 subjects/serotype). For each sample size, 200 
datasets were simulated. The proposed method was applied to the simulated data with 30,000 
iterations for both the burn-in process and the sampling process. Cutoffs were calculated with 
respect to each of the 30,000 samples of parameters for sensitivity values of 0.5, 0.6, 0.7, 0.8, 
and 0.9. The point estimates and c.i.’s of model parameters and cutoffs were obtained from 
each simulation. The averages, biases, and standard errors of these estimates as well as the 
coverage probabilities of c.i.’s of key parameters (β′s and σ′s) and cutoffs are shown in Tables 
3.4 and 3.5, respectively. 
Table 3.4. Averages, biases and standard errors of the point estimates as well as the c.i.’s coverage probabilities 
of the key parameters 
 180 pigs TRUE 
value 
18 pigs 
Avg Bias SE Coverage Avg Bias SE Coverage 
β01 0 0 0.002 0.955 0 −0.002 −0.002 0.013 0.95 
β02 0 0 0.002 0.97 0 −0.001 −0.001 0.01 0.955 
β03 0 0 0.002 0.97 0 −0.001 −0.001 0.01 0.955 
β04 0 0 0.003 0.98 0 −0.001 −0.001 0.011 0.96 
β05 0 0 0.003 0.94 0 0 0 0.011 0.945 
β06 0 0 0.003 0.96 0 −0.001 −0.001 0.011 0.955 
β11 0.15 0 0.012 0.975 0.15 0.147 −0.003 0.043 0.965 
β12 0.301 0.001 0.012 0.97 0.3 0.298 −0.002 0.047 0.95 
β13 0.45 0 0.012 0.97 0.45 0.446 −0.004 0.048 0.95 
β14 0.6 0 0.018 0.945 0.6 0.591 −0.009 0.064 0.96 
β15 0.751 0.001 0.017 0.965 0.75 0.745 −0.005 0.066 0.95 
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Table 3.4 continued 
β16 0.9 0 0.016 0.95 0.9 0.896 −0.004 0.06 0.955 
σ01 0.05 0 0.002 0.96 0.05 0.07 0.02 0.071 0.815 
σ11 0.303 0.003 0.009 0.935 0.3 0.344 0.044 0.076 0.78 
σ02 0.05 0 0.002 0.91 0.05 0.059 0.009 0.012 0.795 
σ12 0.302 0.002 0.009 0.955 0.3 0.355 0.055 0.071 0.805 
σ03 0.051 0.001 0.003 0.96 0.05 0.059 0.009 0.012 0.79 
σ13 0.303 0.003 0.009 0.935 0.3 0.356 0.056 0.071 0.805 
σ04 0.051 0.001 0.003 0.955 0.05 0.06 0.01 0.013 0.85 
σ14 0.303 0.003 0.013 0.96 0.3 0.367 0.067 0.091 0.84 
σ05 0.05 0 0.002 0.915 0.05 0.06 0.01 0.014 0.84 
σ15 0.302 0.002 0.013 0.945 0.3 0.367 0.067 0.09 0.86 
σ06 0.05 0 0.002 0.955 0.05 0.06 0.01 0.013 0.87 
σ16 0.302 0.002 0.013 0.94 0.3 0.36 0.06 0.083 0.89 
 
Table 3.5. Averages, biases and standard errors of the point estimates as well as the c.i.’s coverage probabilities 
of the cutoffs 
Sensitivity  180 pigs TRUE 
value 
18 pigs 
Avg Bias SE Coverage Avg Bias SE Coverage 
0.5 𝑐1 0.15 0 0.014 0.98 0.15 0.145 −0.005 0.055 0.955 
𝑐2 0.301 0.001 0.014 0.975 0.3 0.297 −0.003 0.056 0.95 
𝑐3 0.45 0 0.014 0.975 0.45 0.445 −0.005 0.056 0.955 
𝑐4 0.601 0.001 0.019 0.95 0.6 0.591 −0.009 0.071 0.955 
𝑐5 0.751 0.001 0.018 0.97 0.75 0.745 −0.005 0.073 0.945 
𝑐6 0.901 0.001 0.018 0.95 0.9 0.895 −0.005 0.067 0.96 
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Table 3.5 continued 
0.6 𝑐1 0.074 0 0.014 0.975 0.074 0.058 −0.016 0.052 0.96 
𝑐2 0.224 0 0.014 0.965 0.224 0.207 −0.017 0.063 0.95 
𝑐3 0.373 −0.001 0.014 0.96 0.374 0.355 −0.019 0.063 0.95 
𝑐4 0.524 0 0.02 0.935 0.524 0.498 −0.026 0.08 0.955 
𝑐5 0.675 0.001 0.019 0.97 0.674 0.652 −0.022 0.08 0.945 
𝑐6 0.824 0 0.018 0.95 0.824 0.804 −0.02 0.073 0.955 
0.7 𝑐1 -0.008 −0.001 0.014 0.975 −0.007 −0.035 −0.028 0.057 0.955 
𝑐2 0.142 −0.001 0.014 0.965 0.143 0.111 −0.032 0.074 0.945 
𝑐3 0.291 −0.001 0.014 0.965 0.293 0.258 −0.034 0.074 0.945 
𝑐4 0.442 −0.001 0.021 0.93 0.443 0.398 −0.044 0.096 0.94 
𝑐5 0.593 0 0.02 0.96 0.593 0.552 −0.041 0.093 0.93 
𝑐6 0.742 −0.001 0.019 0.95 0.743 0.706 −0.036 0.086 0.945 
0.8 𝑐1 −0.104 −0.002 0.015 0.965 −0.102 −0.144 −0.042 0.07 0.975 
𝑐2 0.046 −0.001 0.015 0.965 0.048 −0.002 −0.05 0.091 0.93 
𝑐3 0.195 −0.002 0.016 0.955 0.198 0.145 −0.052 0.091 0.925 
𝑐4 0.346 −0.002 0.023 0.93 0.348 0.282 −0.066 0.118 0.92 
𝑐5 0.497 0 0.022 0.95 0.498 0.436 −0.062 0.113 0.92 
𝑐6 0.646 −0.002 0.021 0.95 0.648 0.592 −0.055 0.105 0.93 
0.9 𝑐1 −0.237 −0.003 0.017 0.965 −0.234 −0.295 −0.061 0.095 0.92 
𝑐2 −0.087 −0.002 0.017 0.96 −0.084 −0.158 −0.074 0.117 0.9 
𝑐3 0.062 −0.003 0.018 0.955 0.066 −0.011 −0.077 0.117 0.89 
𝑐4 0.213 −0.003 0.027 0.95 0.216 0.121 −0.095 0.152 0.91 
𝑐5 0.365 −0.001 0.025 0.94 0.366 0.274 −0.091 0.146 0.885 
𝑐6 0.513 −0.003 0.025 0.945 0.516 0.434 −0.082 0.135 0.9 
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From Tables 3.4 and 3.5, we observed the following. 1) The averaged estimates were 
very close to the true values for the simulation studies for 180 subjects (pigs). The averaged 
estimates from 18 subjects were significantly deviated from the true values, especially for 
variances and cutoffs with extreme values. 2) The standard errors of the estimates of key 
parameters and cutoffs were smaller for simulations with 180 subjects. 3) The coverage 
probabilities of the 95% c.i.’s, 91% ~ 98%, were close to the value of 95% for simulations with 
180 subjects. For simulations with 18 subjects, the coverage probabilities related to group 
means and cutoffs (≤0.7) were close to 95%. However, the coverage probabilities for variances 
and cutoffs (≥0.8) were far below 95%.  
 
3.6 Conclusion 
This paper proposed a model based on the normal distribution to analyze clustered data 
with latent classes. The Bayesian method together with MCMC was used because of the 
complexity of this hierarchical model. The data structure in the example of this paper is 
prevalent nowadays, especially in clinical tests. However, it is difficult to analyze such data 
because 1) intra-subject correlations exist if multiple observations were obtained from each of 
the subjects; 2) during the process of calculating the sensitivity and specificity, the true status 
is usually unknown, which makes the model-based estimates the only choice. The true status 
was included in the proposed model as a latent variable. From the simulation study, the 
proposed method can be used to analyze this kind of data and make accurate inferences to the 
true parameters if the sample size is large enough (~180). The estimates of variances and 
cutoffs associated with extreme sensitivity (or specificity) values might be problematic if the 
sample size is as small as 18.  
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CHAPTER 4.    R PACKAGE: CICorr 
Purpose: As discussed previously, many clinical diagnostic tests involve multiple 
measurements from the same subjects, generating intra-subject correlated data values. The 
calculations of the CIs of sensitivity and specificity become challenging because of this 
correlation. In Chapter2, we propose a new method to solve this problem, which outperforms 
current methods according to the coverage probabilities of CIs and the calculating efficiency. 
I create an R package for the 1st project (Chapter 2) so that everyone can install and use it. The 
manual of the R package is attached. 
4.1 Basic information  
Package name CICorr 
Version 0.3  
Date 2017-09-25  
Title calculate the confidence intervals of sensitivity and specificity for intra-subject correlated 
and normally distributed data 
Author Y. Du and C. Wang 
Maintainer Y. Du  
Description This package is used to calculate the confidence intervals of sensitivity and 
specificity for normally-distributed data with intra-subject correlations given cutoff values. 
Depends R (>= 3.4.4), nlme, mnormt 
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4.2 Contents of manual 
CIcorr-package   The ‘CICorr’ package: summary information 
 
Description: 
This package provides a function for computing the CIs of sensitivity and specificity 
for intro-subject correlated and normally distributed data w.r.t given cutoffs. 
Details: 
The package includes a function ‘CI_corr’ which is used to calculate the CI of 
sensitivity and specificity for intra-subject correlated and normally distributed data. 
License: 
Author(s): 
Y. Du (R programmer and package creator), C. Wang (Advisor of methodology). 
References: 
Du Y., 2018. Choosing cutoff values for correlated continuous diagnostic data to 
estimate sensitivity and specificity (Doctoral dissertation). 
CI_corr         Function to calculate CI of sensitivity and specificity 
 
Description: 
 The function is used to calculate the CIs of sensitivity and specificity for a correlated 
and normally distributed data w.r.t given cutoff values. 
Usage: 
    CI_corr(subject, status, y, cut, method) 
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Arguments: 
subject:  a character vector of length d, where d is the 
number of observations, representing the subject 
ID for each observation. 
status:  a vector of either 0 or 1 with length d, 
representing the true status: 0=healthy and 
1=ill 
y:  a numerical vector of length d, representing 
observations 
cut:  specified numerical cutoff(s) 
method:  1 or 2. If 1, the point estimates of sensitivity and 
specificity in the CIs are selected from the 
model-based estimate and empirical estimate 
depending on different situation. If 2, the 
Agresti-Coull estimates are used. 
 
Details: 
This function analyzes data with the linear mixed model to obtain estimates of model 
parameters. The estimates of sensitivity and specificity were calculated for given cutoffs. 
Variance of Empirical sensitivity and specificity were calculated which were functions of 
sensitivity and specificity, respectively. Logit transformation and the back-transformation was 
applied to the calculated sensitivity and specificity to make sure the final CIs were between 
[0,1]. The point estimates of sensitivity and specificity in the CIs can be either a selection 
among empirical estimation and model-based estimation or estimates based on the Agresti-
Coull method. 
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Values:  
 Returns a matrix including the point estimates, upper confidence limits and lower 
confidence limits of sensitivity and specificity w.r.t specified cutoff(s). 
Examples: 
# Compute the CIs of sensitivity and specificity for data "clinical" which possesses 
intra-subject correlations. 
data(clinical) 
CI_corr(subject=clinical$pen,status=(clinical$status=="ill"),y=clinical$log,cut=seq(-
1,0,length.out=4),method=2) 
4.3 R code 
#' CI_corr 
#' 
#' Take in subject, status, response and cutoff and then calculate CI for sensitivity and 
specificity 
#' 
#' @name CI_corr 
#' 
#' @param subject: a character vector of length d, where d is the number of observations, 
representing the subject ID for each observation. 
#' @param status: a vector of either 0 or 1 with length d, representing the true status: 0=healthy 
and 1=ill 
#' @param y: a numerical vector of length d, representing observations 
#' @param cut: specified numerical cutoff(s) 
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#' @param method: 1 or 2, the point estimate in the CI is the mixture of model based estimate 
and empirical estimate for "1" and Agresti-Coull estimate for "2" 
#' @return a matrix includes low and high limits of CI of sensitivity and specificity for different 
cutoffs 
#' @seealso \code{lme} 
#' @seealso \code{pmnorm} 
#' 
#' @details 
#' This function runs the linear mixed regression for y with the random subject effect to obtain 
estimates of model parameters. 
#' Empirical, model-based and Agresti-Coull estimates of sensitivity and specificity are 
calculated for given cutoffs. Variance of Empirical 
#' sensitivity and specificity are calculated which are functions of sensitivity and specificity, 
respectively. Logit transformation and the 
#' back-transformation are applied to the calculated sensitivity and specificity to make sure the 
final CIs are between [0,1]. 
#' @importFrom mnormt pmnorm 
#' @importFrom nlme lme fixef VarCorr 
#' 
#' @examples 
#' ## Compute the CIs of sensitivity and specificity for data "clinical" which possesses intra-
cluster correlations. 
#' data(clinical) 
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#' CI_corr(subject=clinical$pen,status=(clinical$status=="ill"),y=clinical$log,cut=c(-0.5,-
0.6),method=2) 
#' 
#' @export 
CI_corr=function(subject,status,y,cut,method) { 
 CI = matrix(, length(cut), 6) 
    colnames(CI) = c("Spe.est", "Spe.L", "Spe,H", "Sen.est",  
        "Sen.L", "Sen.H") 
    delta = 5 
    data = data.frame(subject = as.factor(subject), status = as.factor(status),  
        y) 
    data = data[order(data$status), ] 
    x = data$y 
    fit = nlme::lme(fixed = y ~ status, random = list(subject = pdSymm(form = ~1)),  
        weights = varIdent(form = ~1 | status), data = data) 
    m.hat = as.vector(nlme::fixef(fit)) 
    sd <- as.numeric(nlme::VarCorr(fit)[, 2]) 
    V = sd^2 
    se.coef = c(1, as.numeric(coef(fit$modelStruct$varStruct,  
        unconstrained = F))) 
    mse.coef = se.coef^2 
    sigma.hat <- matrix(c(mse.coef[1] * V[2], 0, 0, mse.coef[2] *  
        V[2]), 2, 2) + V[1] 
    sigma0.hat <- matrix(c(mse.coef[1] * V[2], 0, 0, mse.coef[1] *  
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        V[2]), 2, 2) + V[1] 
    sigma1.hat <- matrix(c(mse.coef[2] * V[2], 0, 0, mse.coef[2] *  
        V[2]), 2, 2) + V[1] 
    uni_status = unique(as.vector(status)) 
    uni_status = uni_status[order(uni_status)] 
    n0 = as.numeric(table(data[data$status == uni_status[1],  
        1])) 
    N0 = sum(n0) 
    n1 = as.numeric(table(data[data$status == uni_status[2],  
        1])) 
    N1 = sum(n1) 
    if (m.hat[2] > 0) { 
        sen.m <- 1 - pnorm((cut - sum(m.hat))/sqrt(sigma.hat[2,  
            2])) 
        spe.m <- pnorm((cut - m.hat[1])/sqrt(sigma.hat[1, 1])) 
    } 
    else { 
        sen.m <- pnorm((cut - sum(m.hat))/sqrt(sigma.hat[2, 2])) 
        spe.m <- 1 - pnorm((cut - m.hat[1])/sqrt(sigma.hat[1,  
            1])) 
    } 
    for (i in 1:length(cut)) { 
        if (m.hat[2] > 0) { 
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            sen.hat <- sum(x[(N0 + 1):(N0 + N1)] >= cut[i])/N1 
            spe.hat <- sum(x[1:N0] < cut[i])/N0 
            sen.ac <- (sum(x[(N0 + 1):(N0 + N1)] >= cut[i]) +  
                2)/(N1 + 4) 
            spe.ac <- (sum(x[1:N0] < cut[i]) + 2)/(N0 + 4) 
            spe_var.hat <- (spe.m[i])/N0 - (spe.m[i])^2 * (N0 +  
                sum(n0 * (n0 - 1)))/N0^2 + sum(n0 * (n0 - 1))/N0^2 *  
                mnormt::pmnorm(rep((cut[i] - m.hat[1]), 2), varcov = sigma0.hat) 
            sen_var.hat <- (1 - sen.m[i])/N1 - (1 - sen.m[i])^2 *  
                (N1 + sum(n1 * (n1 - 1)))/N1^2 + sum(n1 * (n1 -  
                1))/N1^2 * mnormt::pmnorm(rep((cut[i] - sum(m.hat)),  
                2), varcov = sigma1.hat) 
        } 
        else { 
            sen.hat <- sum(x[(N0 + 1):(N0 + N1)] <= cut[i])/N1 
            sen.ac <- (sum(x[(N0 + 1):(N0 + N1)] <= cut[i]) +  
                2)/(N1 + 4) 
            spe.hat <- sum(x[1:N0] > cut[i])/N0 
            spe.ac <- (sum(x[1:N0] > cut[i]) + 2)/(N0 + 4) 
            spe_var.hat <- (1 - spe.m[i])/N0 - (1 - spe.m[i])^2 *  
                (N0 + sum(n0 * (n0 - 1)))/N0^2 + sum(n0 * (n0 -  
                1))/N0^2 * mnormt::pmnorm(rep((cut[i] - m.hat[1]),  
                2), varcov = sigma0.hat) 
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            sen_var.hat <- (sen.m[i])/N1 - (sen.m[i])^2 * (N1 +  
                sum(n1 * (n1 - 1)))/N1^2 + sum(n1 * (n1 - 1))/N1^2 *  
                mnormt::pmnorm(rep((cut[i] - sum(m.hat)), 2),  
                  varcov = sigma1.hat) 
        } 
        if (method == 1) { 
            sen.final = ifelse(sen.hat > 1 - delta/N1 | sen.hat <  
                delta/N1, sen.m[i], sen.hat) 
            spe.final = ifelse(spe.hat > 1 - delta/N0 | spe.hat <  
                delta/N0, spe.m[i], spe.hat) 
        } 
        else { 
            sen.final = sen.ac 
            spe.final = spe.ac 
        } 
        M.var <- sen_var.hat/sen.m[i]^2/(1 - sen.m[i])^2 
        M.est <- log(sen.final/(1 - sen.final)) 
        M.l <- M.est - 1.96 * sqrt(M.var) 
        M.h <- M.est + 1.96 * sqrt(M.var) 
        CI[i, 4:6] = exp(c(M.est, M.l, M.h))/(1 + exp(c(M.est,  
            M.l, M.h))) 
        M.var <- spe_var.hat/spe.m[i]^2/(1 - spe.m[i])^2 
        M.est <- log(spe.final/(1 - spe.final)) 
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        M.l <- M.est - 1.96 * sqrt(M.var) 
        M.h <- M.est + 1.96 * sqrt(M.var) 
        CI[i, 1:3] = exp(c(M.est, M.l, M.h))/(1 + exp(c(M.est,  
            M.l, M.h))) 
  } 
 return(CI) 
} 
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CHAPTER 5.    SUMMARY AND FUTURE WORK 
5.1 Summary 
In this dissertation, we propose appropriate statistical methods focusing on two 
challenges when working on the diagnostic test data: correlations and unknown statuses. 
Chapter 2 develops a method to calculate the CIs of sensitivity and specificity for correlated 
and continuous data with given true statuses. In chapter 3, we propose a hierarchical Bayesian 
model to analyze the data with unknown statuses and further to estimate the sensitivity and 
specificity. We also create an R package for the 1st project for future use. Both methods are 
developed for clinical diagnostic test data, but their applications are not limited to diagnostic 
tests. They apply to projects of other areas if the data properties are similar. 
In Chapter 2, we propose a new method to calculate the CIs of sensitivity and specificity 
for intra-subject-correlated data based on the normal distribution. In the new method, variances 
of Sen̂ and Spê are calculated as a function of model parameters. The logit transformation and 
the corresponding back-transformation are used to ensure the ranges of the calculated CIs are 
limited to [0,1]. The simulation studies show that the CIs calculated using the proposed method 
overall possess more reasonable CPs and reduced the risk of the convergence problem. In 
addition, the new method is more efficient than the current binary-data-based methods because 
different choices of cutoff values don’t require re-analysis of data. This is an important 
advantage when multiple cutoff values are required. We created an R package for this method 
for future use. 
In Chapter 3, we propose a model based on the normal distribution to analyze clustered 
data with unknown statuses. The unknown statuses are modeled by a latent variable. The 
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Bayesian method is used because of the complexity of this hierarchical model. From the 
simulation study, the proposed method can be used to analyze this kind of data and make 
accurate inferences to the true parameters if the sample size is large enough (180) and thus can 
be used to select cutoff values given borderline values of sensitivity or specificity. 
5.2 Future work 
The first method is based on the normal distribution. We can obviously extend the main 
idea to the data following a distribution other than the normal distribution. However, the 
derivation of variances of the estimated sensitivity and specificity might be a big challenge.   
In the second project, the model only includes one latent variable because it is 
reasonable to assume all subjects are in the status of “infection” and we only need to model 
the unknown antibody status. However, in a diagnostic test, it is not a rare case if both the 
subject status and the antibody status are unknown. We can obviously extend our idea and 
model the two statuses with two latent variables. The challenge point is that the probability 
that an antibody has a reaction is dependent on the disease status of the subject. If there is no 
further assumptions to simplify the model, the model will include 50+ parameters, which 
makes the convergence hard if not impossible. Then how to simplify the model? We can try 
assuming all the 4 serovars have similar influences and thus the probabilities to stimulate a 
type of antibody don’t differ from the types of serovars. Although this assumption might not 
reasonable in biology, it is worth trying from the perspective of statistics. Finally, if we 
encounter both correlated data and unknown statuses in a project, can we find an effective way 
to calculate the CIs of sensitivity and specificity? All these questions need further investigation.
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